Team

Buxbaum headshot in lab_lower resJoseph D. Buxbaum, PhD – Principal Investigator

Dr. Buxbaum is the G. Harold and Leila Y. Mathers Professor of Psychiatry, Neuroscience, and Genetic and Genomic Sciences, the Head of The Laboratory of Molecular Neuropsychiatry, and the Vice Chair for Research in the Department of Psychiatry at Mount Sinai. Dr. Buxbaum is the Director of the Seaver Autism Center, and his research focuses on using techniques of molecular genetics and neurobiology to identify, and ultimately characterize, genes that contribute to autism susceptibility. His laboratory has identified common and rare genetic variants that underlie ASD and has developed model systems in which novel therapeutics rlan be tested. In addition, Dr. Buxbaum has taken a lead in several international consortia, most recently the Autism Sequencing Consortium aimed at sequencing 20,000 exomes, dedicated to advancing research in ASD. Dr. Buxbaum is the author of more than 200 publications, and he is co-editor-inchief of the journal Molecular Autism.

0000072500001497250952Jennifer Reichert – Lab Manager

Bio

I was born in Regina, Saskatchewan and raised in Quito, Ecuador. I have a B.S. from Fordham University. Prior to joining Dr. Buxbaum’s laboratory, I worked at LifeCodes in Stamford, CT doing HLA genotyping.

Research Interests

I am currently researching the genetics of autism.

Techniques

DNA Isolation, RNA Isolation, sequencing, genotyping, nanodrop

Other Interests

I am a playwright and the General Manager of The CRY HAVOC Company.